Bryan Supran
Direttore/Membro del Consiglio presso ANACOR PHARMACEUTICALS INC
Patrimonio netto: 212 553 $ in data 30/04/2024
Profilo
Bryan Supran is currently the Director & Vice President at Array BioPharma, Inc., the Director at Anacor Pharmaceuticals LLC, the Non-Executive Director at Haleon Plc, and the Senior Vice President & Deputy General Counsel at Pfizer Inc. He previously worked as a Director at Medivation LLC (California), Viatris, Inc., and Haleon UK Holdings (No.2) Ltd.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
HALEON PLC
0.00% | 31/12/2023 | 50 000 ( 0.00% ) | 212 553 $ | 30/04/2024 |
Posizioni attive di Bryan Supran
| Società | Posizione | Inizio |
|---|---|---|
| ANACOR PHARMACEUTICALS INC | Direttore/Membro del Consiglio | 24/06/2016 |
| ARRAY TECHNOLOGIES, INC. | Direttore/Membro del Consiglio | 30/07/2019 |
| HALEON PLC | Direttore/Membro del Consiglio | 18/07/2022 |
| PFIZER, INC. | Consigliere Generale | 01/04/2016 |
Precedenti posizioni note di Bryan Supran
| Società | Posizione | Fine |
|---|---|---|
Haleon UK Holdings (No.2) Ltd.
 Haleon UK Holdings (No.2) Ltd. Financial ConglomeratesFinance Part of Haleon Plc, Haleon UK Holdings (No.2) Ltd. is an investment holding company. Haleon UK Holdings (No.2) Ltd. is based in Weybridge, UK. Founded in 2019, Haleon UK Holdings (No.2 functions as an investment holding company. | Direttore/Membro del Consiglio | 18/07/2022 |
| VIATRIS INC. | Direttore/Membro del Consiglio | 16/11/2020 |
| MEDIVATION INC | Direttore/Membro del Consiglio | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| VIATRIS INC. | Health Technology |
| HALEON PLC | Distribution Services |
| PFIZER, INC. | Health Technology |
| Aziende private | 4 |
|---|---|
Anacor Pharmaceuticals LLC
 Anacor Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Anacor Pharmaceuticals, Inc. develops medical solutions. The firm operates as a biopharmaceutical company, which focuses on discovering, developing, and commercializing novel small-molecule therapeutics derived from its boron chemistry platform. The company was founded by Lucy Shapiro, Stephen J. Benkovic, and David P. Perry in 2000 and is headquartered in Palo Alto, CA. | Health Technology |
Medivation LLC (California)
 Medivation LLC (California) Pharmaceuticals: MajorHealth Technology Medivation LLC engages in the development and commercialization of novel therapies to treat serious diseases for which there are limited treatment options. The company was founded by Clarence Patrick Machado and David T. Hung in 2004 and is headquartered in San Francisco, CA. | Health Technology |
Array BioPharma, Inc.
 Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Array BioPharma, Inc. is a biopharmaceutical company. Its focus is on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and other high-burden diseases. The company's products are BRAFTOVI and MEKTOVI. Its portfolio includes Binimetinib, Selumetinib, Encorafenib, Filanesib, Ipatasertib, Varltinib, Danoprevir, ARRY-797, Larotrectinib, Tucatinib, ARRY-382, Motolimod, Prexasertib, GDC-0575, LOXO-292, LOXO-195, and AK-1830. The company was founded by Kevin Koch, Anthony D. Piscopio, K. C. Nicolaou, and David L. Snitman in 1998 and is headquartered in Boulder, CO. | Health Technology |
Haleon UK Holdings (No.2) Ltd.
Haleon UK Holdings (No.2) Ltd. Financial ConglomeratesFinance Part of Haleon Plc, Haleon UK Holdings (No.2) Ltd. is an investment holding company. Haleon UK Holdings (No.2) Ltd. is based in Weybridge, UK. Founded in 2019, Haleon UK Holdings (No.2 functions as an investment holding company. | Finance |
- Borsa valori
- Insiders
- Bryan Supran
